UK markets close in 5 hours 50 minutes

CureVac N.V. (CVAC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.2100-0.0900 (-2.73%)
At close: 04:00PM EDT
3.2400 +0.03 (+0.93%)
After hours: 07:27PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 718.80M
Enterprise value 255.78M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)14.63
Price/book (mrq)1.10
Enterprise value/revenue 5.96
Enterprise value/EBITDA -0.92

Trading information

Stock price history

Beta (5Y monthly) 2.53
52-week change 3-53.68%
S&P500 52-week change 328.64%
52-week high 312.3600
52-week low 33.1900
50-day moving average 33.5460
200-day moving average 36.5412

Share statistics

Avg vol (3-month) 3966.1k
Avg vol (10-day) 3807.12k
Shares outstanding 5223.92M
Implied shares outstanding 6223.92M
Float 8118.65M
% held by insiders 145.43%
% held by institutions 123.77%
Shares short (29 Feb 2024) 44.39M
Short ratio (29 Feb 2024) 45.6
Short % of float (29 Feb 2024) 411.06%
Short % of shares outstanding (29 Feb 2024) 41.96%
Shares short (prior month 31 Jan 2024) 44.14M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-332.92%

Management effectiveness

Return on assets (ttm)-18.03%
Return on equity (ttm)-49.26%

Income statement

Revenue (ttm)42.88M
Revenue per share (ttm)0.20
Quarterly revenue growth (yoy)47.00%
Gross profit (ttm)N/A
EBITDA -242.09M
Net income avi to common (ttm)-302.3M
Diluted EPS (ttm)-1.6000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)464.14M
Total cash per share (mrq)2.07
Total debt (mrq)42.11M
Total debt/equity (mrq)6.99%
Current ratio (mrq)3.56
Book value per share (mrq)2.69

Cash flow statement

Operating cash flow (ttm)-273.37M
Levered free cash flow (ttm)-211.2M